Bookbuilding IPO | ₹60 Cr | Listing at BSE, NSE | Mon, Mar 29, 2004 - Wed, Apr 7, 2004 P
DISHMAN PHARMACEUTICALS CHEMICALS IPO is a book build issue of ₹60.09 crores. The issue is entirely a fresh issue of 0.34 crore shares of ₹60.09 crore.
DISHMAN PHARMACEUTICALS CHEMICALS IPO bidding started from Mar 29, 2004 and ended on Apr 7, 2004.
DISHMAN PHARMACEUTICALS CHEMICALS IPO is set final issue price at ₹175 per share.
Axis Capital Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to for detailed Information.
IPO Open
Mon, Mar 29, 2004
IPO Close
Wed, Apr 7, 2004
Issue Price
₹175 per share
Market Cap (Pre-IPO)
₹240.34 Cr
| IPO Date | 29 Mar to 7 Apr, 2004 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹155 to ₹175 |
| Issue Price | ₹175 per share |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 34,33,500 shares (agg. up to ₹60 Cr) |
| Fresh Issue | 34,33,500 shares (agg. up to ₹60 Cr) |
| Share Holding Pre Issue | 1,03,00,000 shares |
| Share Holding Post Issue | 1,37,33,500 shares |
DISHMAN PHARMACEUTICALS CHEMICALS IPO comprises a total issue size of 34,33,500 shares. Out of which, 17,16,700 (50.00%) are allocated to QIB, 8,58,400 (25.00%) allocated to NII 8,58,400 (25.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue |
|---|---|---|
| QIB Shares Offered | 17,16,700 | 50.00% |
| NII (HNI) Shares Offered | 8,58,400 | 25.00% |
| Retail Shares Offered | 8,58,400 | 25.00% |
| Total Shares Offered | 34,33,500 | 100.00% |
Incorporated on June 29, 1983, Dishman Pharmaceuticals and Chemicals Limited operates in specialty chemicals, QUATs, intermediates, APIs, and Contract Manufacturing & Research (CM & CR) segments. The company manufactures pharmaceutical and chemical products for domestic and international markets through its Bavla and Naroda facilities in Gujarat.
The company offers regular and customized manufacturing services, including APIs, specialty chemicals, phase transfer catalysts (PTCs), and contract research solutions. Its facilities include GMP-compliant production units, R&D laboratories, solvent recovery systems, and quality control infrastructure.
The company serves pharmaceutical and chemical companies across regulated and non-regulated global markets. As of November 30, 2003, the company had around 480 employees.
Competitive Strengths
| Period Ended | 30 Sep 2003 | 31 Mar 2003 | 31 Mar 2002 | 31 Mar 2001 |
|---|---|---|---|---|
| Total Income | 57.82 | 104.39 | 87.34 | 80.39 |
| Profit After Tax | 5.56 | 14.26 | 7.10 | 6.46 |
| NET Worth | 51.97 | 46.37 | 33.98 | 30.19 |
| Reserves and Surplus | 43.88 | 38.36 | 26.05 | 19.85 |
| Total Borrowing | 100.56 | 101.61 | 103.50 | 74.56 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Site development | 0.40 |
| 2 | GMP API plant | 11.75 |
| 3 | GMP intermediate plant | 6.25 |
| 4 | Dedicated research and development center | 9.50 |
| 5 | Expansion of existing facilities | 3.00 |
| 6 | Expansion of existing common utilities | 8.50 |
| 7 | Provision for contingencies | 1.50 |
| 8 | Working Capital margin | 8.00 |
| 9 | Issue expenses | 3.60 |
| Total | 52.50 |
| KPI | Sep 30, 2003 | Mar 31, 2003 |
|---|---|---|
| RoNW | 10.70% | 30.74% |
| Price to Book Value | 3.47 | 3.89 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 13.84 | 8.10 |
| P/E (x) | 12.64 | 21.61 |
| Promoter Holding | 99.994% | 74.99% |
| Market Cap | ₹240.34 Cr. |
The DISHMAN PHARMACEUTICALS CHEMICALS IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | |
|---|---|---|---|---|
| Total | 38.41 | 34,33,500 | 13,18,76,200 | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Marketing Costs ( Advertising expense, Road Shows) | 0.50 |
| 2 | Printing, Registrar Cost, stamp duty, Listing and Depository Costs | 0.66 |
| 3 | Fees payable to BRLMs, Legal Counsel, Auditors | 2.44 |
| Total | 3.60 |
Lead Manager Reports
DISHMAN PHARMACEUTICALS CHEMICALS IPO is a main-board IPO of 34,33,500 equity shares of the face value of ₹10 aggregating up to ₹60 Crores. The issue is priced at ₹175 per share. The minimum order quantity is .
The IPO opens on Mon, Mar 29, 2004, and closes on Wed, Apr 7, 2004.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in DISHMAN PHARMACEUTICALS CHEMICALS IPO using UPI as a payment gateway. Zerodha customers can apply in DISHMAN PHARMACEUTICALS CHEMICALS IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in DISHMAN PHARMACEUTICALS CHEMICALS IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The DISHMAN PHARMACEUTICALS CHEMICALS IPO opens on Mon, Mar 29, 2004 and closes on Wed, Apr 7, 2004.
DISHMAN PHARMACEUTICALS CHEMICALS IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in DISHMAN PHARMACEUTICALS CHEMICALS IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for DISHMAN PHARMACEUTICALS CHEMICALS IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the DISHMAN PHARMACEUTICALS CHEMICALS IPO allotment status.
The DISHMAN PHARMACEUTICALS CHEMICALS IPO listing date is not yet announced. The tentative date of listing is .
